Key result
Combined systolic-diastolic hypertension linked to ~84% higher risk of cardiovascular death.
Why the study?
The combined effect of systolic and diastolic hypertension on cardiovascular disease mortality and the appropriate blood pressure cutpoints remain unclear.
Does combined systolic and diastolic hypertension increase cardiovascular disease death in community-dwelling adults?
Cohort (n=14,375)
Yes
Does combined systolic and diastolic hypertension increase cardiovascular disease death in community-dwelling adults?
This study demonstrates that the combination of elevated systolic and diastolic blood pressure is a stronger predictor of cardiovascular disease mortality than either elevated component alone.
May inform combined BP phenotype for CVD mortality risk stratification; hypothesis-generating, needs prospective confirmation before practice change.
OBJECTIVES: This study aimed to examine the risk of cardiovascular disease (CVD) death according to blood pressure levels and systolic and/or diastolic hypertension. METHODS: From 20,636 cohort participants, 14,375 patients were enrolled after patients with prior hypertension on antihypertensive drugs were excluded. For the combination analysis, participants were divided into four groups (systolic/diastolic hypertension, systolic hypertension only, diastolic hypertension only, and non-hypertension). The risk of CV death was calculated using the hazard ratio (HR) and 95% confidence intervals (95% CI) in a Cox regression model. RESULTS: The risk of CVD death increased in systolic hypertension (HR = 1.59, 95% CI 1.26-2.00) and systolic/diastolic hypertension (HR = 1.84, 95% CI 1.51-2.25). The highest risks of hemorrhagic and ischemic stroke were observed in the diastolic hypertension (HR = 4.11, 95% CI 1.40-12.06) and systolic/diastolic hypertension groups (HR = 2.59, 95% CI 1.92-3.50), respectively. The risk of CVD death was drastically increased in those with SBP≥120 mmHg/DBP≥80 mmHg. The highest risk was observed in those with SBP of 130-131 mmHg and 134-137 mmHg. CONCLUSION: The combined analysis of systolic and/or diastolic hypertension appears to be a good predictor of CVD death. The risk of CVD death in the prehypertensive group could be carefully monitored as well as in the hypertensive group, presumably due to less attention and the lack of antihypertensive treatment.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2022) conducted a cohort in Community-dwelling adults (n=14,375). Combined systolic and diastolic hypertension (SBP ≥130 mmHg and DBP ≥85 mmHg) vs. Normal blood pressure (SBP <130 mmHg and DBP <85 mmHg) was evaluated on Cardiovascular disease (CVD) death (HR 1.84, 95% CI 1.51-2.25, p=<0.001). Combined systolic and diastolic hypertension (SBP ≥130 mmHg and DBP ≥85 mmHg) increased the risk of cardiovascular disease death by 84% compared to normal blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: